Sam Lipworth
Cited by
Cited by
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
KJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, ...
Nature medicine 27 (2), 270-278, 2021
Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
PM Short, SIW Lipworth, DHJ Elder, S Schembri, BJ Lipworth
Bmj 342, 2011
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ...
Nature medicine 27 (2), 279-288, 2021
Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing
CRyPTIC Consortium and the 100,000 Genomes Project
New England Journal of Medicine 379 (15), 1403-1415, 2018
Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review
A Dagens, L Sigfrid, E Cai, S Lipworth, V Cheng, E Harris, P Bannister, ...
bmj 369, 2020
The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD
PM Short, PA Williamson, DHJ Elder, SIW Lipworth, S Schembri, ...
Chest 141 (1), 81-86, 2012
Defining dormancy in mycobacterial disease
S Lipworth, RJH Hammond, VO Baron, Y Hu, A Coates, SH Gillespie
Tuberculosis 99, 131-142, 2016
Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection
B Lipworth, R Chan, S Lipworth, CRW Kuo
The Journal of Allergy and Clinical Immunology: In Practice 8 (6), 1798-1801, 2020
SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex
S Lipworth, R Jajou, A de Neeling, P Bradley, W van der Hoek, ...
Emerging Infectious Diseases, 2019
Whole-Genome Sequencing for Predicting Clarithromycin Resistance in Mycobacterium abscessus
S Lipworth, N Hough, L Leach, M Morgan, K Jeffery, M Andersson, ...
Antimicrobial agents and chemotherapy 63 (1), 10.1128/aac. 01204-18, 2019
Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?
RJH Hammond, VO Baron, K Oravcova, S Lipworth, SH Gillespie
Journal of Antimicrobial Chemotherapy 70 (10), 2823-2827, 2015
Genomic surveillance of Escherichia coli and Klebsiella spp. in hospital sink drains and patients
B Constantinides, KK Chau, TP Quan, G Rodger, MI Andersson, K Jeffery, ...
Microbial genomics 6 (7), e000391, 2020
Comparison of R9. 4.1/Kit10 and R10/Kit12 Oxford Nanopore flowcells and chemistries in bacterial genome reconstruction
ND Sanderson, N Kapel, G Rodger, H Webster, S Lipworth, TL Street, ...
Microbial genomics 9 (1), 000910, 2023
Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review
E Webb, I Rigby, M Michelen, A Dagens, V Cheng, AM Rojek, D Dahmash, ...
BMJ global health 7 (8), e009838, 2022
Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK
S Lipworth, KD Vihta, K Chau, L Barker, S George, J Kavanagh, T Davies, ...
Genome medicine 13, 1-13, 2021
Preparing clinicians for (re-) emerging arbovirus infectious diseases in Europe
L Sigfrid, C Reusken, I Eckerle, V Nussenblatt, S Lipworth, J Messina, ...
Clinical Microbiology and Infection 24 (3), 229-239, 2018
The system can't perform the operation now. Try again later.
Articles 1–20